
NASDAQHealthcareMedical - Diagnostics & Research
最新資料
US$524.15
+US$6.145 · +1.19%
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
一般交易時段
US$524.15
+US$6.145 · +1.19%
盤中時間採用ET。市場資料可能有所延遲。
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
日內區間
目前US$524.15
52週區間
目前US$524.15
盤中時間採用ET。市場資料可能有所延遲。
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
日內區間
目前US$524.15
52週區間
目前US$524.15
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 43.04億 USD | 38.98億 USD | 36.61億 USD | 33.67億 USD | 32.15億 USD |
| 銷貨成本 | 16.44億 USD | 15.19億 USD | 14.71億 USD | 13.63億 USD | 13.26億 USD |
| 毛利 | 26.6億 USD | 23.79億 USD | 21.9億 USD | 20.04億 USD | 18.89億 USD |
| 研究與開發 | 2.51億 USD | 2.2億 USD | 1.91億 USD | 2.55億 USD | 1.61億 USD |
| 銷售、一般及管理費用 | 10.48億 USD | 10.31億 USD | 9.02億 USD | 8.51億 USD | 7.96億 USD |
| 營業費用 | 13億 USD | 12.51億 USD | 10.93億 USD | 11.06億 USD | 9.57億 USD |
| 利息收入 | 242.3萬 USD | 1269.9萬 USD | 562.9萬 USD | 106.5萬 USD | 43.4萬 USD |
| 利息支出 | 3826.5萬 USD | 3120.5萬 USD | 4158.1萬 USD | 3985.8萬 USD | 2980.8萬 USD |
| 折舊和攤銷 | 1.45億 USD | 1.3億 USD | 1.15億 USD | 1.12億 USD | 1.05億 USD |
| 營業利益 | 13.6億 USD | 11.28億 USD | 10.97億 USD | 8.99億 USD | 9.32億 USD |
| 淨利 | 10.59億 USD | 8.88億 USD | 8.45億 USD | 6.79億 USD | 7.45億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T789.4億0.06%129.43兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI13.95億0.06%2.3兆 USD0.03%US$381.59-0.09%
Vanguard S&P 500 ETFVOO11.66億0.07%1.8兆 USD0.03%US$715.24-0.05%
Vanguard Morningstar Mid-Cap ETFVO9.5億0.42%2264億 USD0.03%US$80.92-0.27%
Invesco QQQ Trust, Series 1QQQ8.51億0.17%5060.67億 USD0.18%US$746.08-0.69%
iShares Core S&P 500 ETFIVV5.43億0.06%8964.4億 USD0.03%US$781.47-0.06%
Vanguard Morningstar Growth ETFVUG5.2億0.14%3846億 USD0.03%US$91.67-0.33%
State Street SPDR S&P 500 ETFSPY4.97億0.06%8172億 USD0.09%US$778.1-0.06%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Invesco QQQ Trust, Series 1QQQ
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Growth ETFVUG
State Street SPDR S&P 500 ETFSPYAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。